Wednesday, May 27, 2015 1:31:55 PM
Which seems strange to me insofar as one could make the argument that this could be one of the best and least risky times to be 100% invested in MNTA, considering
1) the news flow opportunities (court case & pipeline related)
2) the recent offering @19 (which would seem to imply some large holders see much higher prices in the future)
3) the substantial and perhaps prolonged cash infusion from mCopax (assuming the post approval response from the FDA is as telling as it appeared to be)
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM